MYD88 and cancer: Figure 7 shows that, similar to the test series, expression of both microRNAs was significantly increased in MyD88 negative cancers relative to the MyD88 positive group (miR-21, p = 0.0046; miR-146a, p = 0.0191), with more biological heterogeneity observed with miR-146a levels.